Palisade Capital Management LLC NJ reduced its position in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 25.2% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 10,880 shares of the company’s stock after selling 3,665 shares during the period. Palisade Capital Management LLC NJ’s holdings in Henry Schein were worth $1,991,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently bought and sold shares of the stock. SpiderRock Advisors LLC purchased a new position in Henry Schein during the first quarter worth $102,000. Lee Financial Co purchased a new position in Henry Schein during the second quarter worth $161,000. Westside Investment Management Inc. purchased a new position in Henry Schein during the first quarter worth $168,000. JNBA Financial Advisors purchased a new position in Henry Schein during the first quarter worth $170,000. Finally, Peddock Capital Advisors LLC raised its position in Henry Schein by 29.1% in the first quarter. Peddock Capital Advisors LLC now owns 1,097 shares of the company’s stock worth $186,000 after buying an additional 247 shares during the period. Hedge funds and other institutional investors own 90.87% of the company’s stock.

Shares of Henry Schein, Inc. (HSIC) opened at 174.02 on Wednesday. The firm has a 50-day moving average price of $183.03 and a 200-day moving average price of $174.57. The firm has a market cap of $13.80 billion, a P/E ratio of 26.45 and a beta of 1.09. Henry Schein, Inc. has a 12-month low of $146.23 and a 12-month high of $186.99.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings results on Tuesday, August 8th. The company reported $1.75 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.74 by $0.01. Henry Schein had a return on equity of 19.74% and a net margin of 4.53%. The company had revenue of $3.06 billion during the quarter, compared to analysts’ expectations of $3.05 billion. During the same quarter in the prior year, the business posted $1.64 earnings per share. The company’s revenue for the quarter was up 6.4% compared to the same quarter last year. On average, equities research analysts expect that Henry Schein, Inc. will post $7.29 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: This story was originally reported by Daily Political and is the sole property of of Daily Political. If you are reading this story on another publication, it was stolen and republished in violation of United States & international trademark & copyright laws. The correct version of this story can be accessed at https://www.dailypolitical.com/2017/08/09/palisade-capital-management-llc-nj-has-1-99-million-position-in-henry-schein-inc-nasdaqhsic.html.

A number of equities analysts recently weighed in on the stock. Barrington Research lifted their price objective on shares of Henry Schein from $196.00 to $198.00 and gave the company an “outperform” rating in a research report on Wednesday, May 10th. Zacks Investment Research upgraded shares of Henry Schein from a “hold” rating to a “buy” rating and set a $204.00 price objective on the stock in a research report on Thursday, May 25th. Credit Suisse Group reiterated a “hold” rating and issued a $160.00 price objective on shares of Henry Schein in a research report on Thursday, July 13th. Craig Hallum assumed coverage on shares of Henry Schein in a research report on Tuesday, April 11th. They issued a “hold” rating on the stock. Finally, Stifel Nicolaus lifted their price objective on shares of Henry Schein from $174.00 to $178.00 and gave the company a “hold” rating in a research report on Wednesday, May 10th. One investment analyst has rated the stock with a sell rating, ten have assigned a hold rating and seven have given a buy rating to the company. Henry Schein presently has an average rating of “Hold” and an average price target of $185.56.

In other news, EVP Gerald A. Benjamin sold 12,578 shares of the stock in a transaction on Thursday, May 11th. The stock was sold at an average price of $175.10, for a total value of $2,202,407.80. Following the completion of the transaction, the executive vice president now owns 44,061 shares of the company’s stock, valued at $7,715,081.10. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Corporate insiders own 1.27% of the company’s stock.

Henry Schein Company Profile

Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.

Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC).

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with MarketBeat.com's FREE daily email newsletter.